Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- allogeneic processed thymus tissue
- Ibrance (palbociclib)
Interactions between your drugs
palbociclib allogeneic processed thymus tissue
Applies to: Ibrance (palbociclib), allogeneic processed thymus tissue
Patients that have been treated with palbociclib should let their doctor know before receiving allogeneic processed thymus tissue. Depending on the dose and length of time they have been on palbociclib, they may be at risk for reduced effects of allogeneic processed thymus tissue. Their doctor may already be aware of the risks, but has determined that this is the best course of treatment and has taken appropriate precautions and is monitoring closely for any potential complications. Patients should contact their doctor if their symptoms worsen or their condition changes during treatment with these medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
palbociclib food
Applies to: Ibrance (palbociclib)
Palbociclib oral capsules (Ibrance) should be taken with food to help with its absorption. Palbociclib oral tablets (Ibrance) may be taken with or without food. Do not consume grapefruit or grapefruit juice during treatment with palbociclib. Grapefruit and grapefruit juice can interact with palbociclib and increase the levels of palbociclib in your body. You may be more likely to experience side effects such as nausea; vomiting; diarrhea; loss of appetite; mouth sores; hair loss; weakness; pain, numbness, or tingling in the hands and feet; and impaired bone marrow function resulting in low numbers of different types of blood cells, which can increase the risk of anemia, bleeding problems, and infections. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Copaxone
Copaxone is used to treat relapsing forms of multiple sclerosis (MS) in adults (including ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Mozobil
Mozobil helps patients with non-Hodgkin's lymphoma by releasing stem cells that can be collected ...
Xolremdi
Xolremdi is used to treat WHIM syndrome in adults and children 12 years of age and older to ...
Plerixafor
Plerixafor systemic is used for hematopoietic stem cell mobilization, multiple myeloma ...
Mavorixafor
Mavorixafor is used to treat WHIM syndrome (warts, hypogammaglobulinemia, infections, and ...
Glatiramer
Glatiramer acetate (brand name Copaxone, Glatopa, and generics) is used to treat relapsing forms of ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.